Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsChild and adolescent psychiatry — anxiety disorders

Psych · Child and adolescent psychiatry — anxiety disorders

Child and adolescent anxiety

Also known as Paediatric anxiety · Youth anxiety disorders · Separation anxiety disorder · Child GAD · Adolescent social anxiety · School refusal · Selective mutism · CAMS trial · Coping Cat

Exam-exhaustive fellowship reference on child and adolescent anxiety — separation anxiety, GAD, social anxiety, selective mutism, school refusal functional analysis, exposure-based CBT, SSRI evidence (CAMS, RUPP, fluoxetine, paroxetine, duloxetine), family accommodation, and stepped care. FRANZCP-primary, globally tagged.

high25 referencesUpdated 26 July 202615 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Active suicidal ideation, intent or plan, or escalating self-harm in an anxious youth — same-day risk assessment and safety planning, not 'anxiety only' reassurance
  • Severe school refusal with medical red flags (weight loss, dehydration, unexplained neurological signs) or prolonged complete non-attendance — urgent MDT and medical review
  • Acute panic with chest pain, syncope, or first presentation needing organic exclusion before pure psychiatric labelling
  • Marked behavioural activation, new or worsening suicidal thinking after starting an antidepressant — urgent review and dose/treatment reassessment
  • Safeguarding concerns (abuse, neglect, bullying with safety risk, exploitation) disclosed in anxiety assessment — escalate per local child protection pathways
  • Inability to leave home with extreme avoidance and carer collapse — escalate intensity of care and legal least-restrictive options if capacity and risk require it
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Active suicidal ideation, intent or plan, or escalating self-harm in an anxious youth — same-day risk assessment and safety planning, not 'anxiety only' reassurance
  • Severe school refusal with medical red flags (weight loss, dehydration, unexplained neurological signs) or prolonged complete non-attendance — urgent MDT and medical review
  • Acute panic with chest pain, syncope, or first presentation needing organic exclusion before pure psychiatric labelling
  • Marked behavioural activation, new or worsening suicidal thinking after starting an antidepressant — urgent review and dose/treatment reassessment
  • Safeguarding concerns (abuse, neglect, bullying with safety risk, exploitation) disclosed in anxiety assessment — escalate per local child protection pathways
  • Inability to leave home with extreme avoidance and carer collapse — escalate intensity of care and legal least-restrictive options if capacity and risk require it
The one-line answer

Youth anxiety disorders are common, impairing and highly treatable. Exposure-based CBT is first-line psychological care; SSRIs — sertraline, fluoxetine, fluvoxamine as the evidence anchors — are first-line pharmacotherapy when medication is indicated; combination CBT plus sertraline gave the highest acute response in CAMS. School refusal is a behaviour, not a diagnosis — formulate its function and build a graded return. Always monitor activation and suicidality when starting an antidepressant in a young person.[1][4][5][11]

Meet the patient

An 11-year-old has missed nineteen school days this term. Every one of them started the same way: awake at 6am, abdominal pain by 7, vomiting by 7:30, and completely well by 10am watching television. Three normal paediatric work-ups. Two open-ended medical certificates. Her mother now drives her to school, sits in the car park, and drives her home again.[17][18]

Nobody in this story is doing anything unreasonable. Everyone is making it worse. The examiner's question is "what is the non-attendance achieving, and who is paying for it?" — and the answer decides the treatment.[17][18]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References25ShowHide
  1. [1]Walkup JT, Albano AM, Piacentini J, Birmaher B, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety N Engl J Med, 2008.PMID 18974308
  2. [2]Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents N Engl J Med, 2001.PMID 11323729
  3. [3]Birmaher B, Axelson DA, Monk K, Kalas C, et al. Fluoxetine for the treatment of childhood anxiety disorders J Am Acad Child Adolesc Psychiatry, 2003.PMID 12649628
  4. [4]James AC, Reardon T, Soler A, James G, Creswell C. Cognitive behavioural therapy for anxiety disorders in children and adolescents Cochrane Database Syst Rev, 2020.PMID 33196111
  5. [5]Walter HJ, Bukstein OG, Abright AR, Keable H, Ramtekkar U, et al. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders J Am Acad Child Adolesc Psychiatry, 2020.PMID 32439401
  6. [6]Connolly SD, Bernstein GA Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders J Am Acad Child Adolesc Psychiatry, 2007.PMID 17242630
  7. [7]Ginsburg GS, Becker EM, Keeton CP, Sakolsky D, et al. Naturalistic follow-up of youths treated for pediatric anxiety disorders JAMA Psychiatry, 2014.PMID 24477837
  8. [8]Ginsburg GS, Becker-Haimes EM, Keeton C, Kendall PC, et al. Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes J Am Acad Child Adolesc Psychiatry, 2018.PMID 29960692
  9. [9]Ginsburg GS, Kendall PC, Sakolsky D, Compton SN, et al. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS J Consult Clin Psychol, 2011.PMID 22122292
  10. [10]Wang Z, Whiteside SPH, Sim L, Farah W, et al. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis JAMA Pediatr, 2017.PMID 28859190
  11. [11]Bridge JA, Iyengar S, Salary CB, Barbe RP, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials JAMA, 2007.PMID 17440145
  12. [12]Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V Psychiatr Clin North Am, 2009.PMID 19716988
  13. [13]Shear K, Jin R, Ruscio AM, Walters EE, Kessler RC. Prevalence and correlates of estimated DSM-IV child and adult separation anxiety disorder in the National Comorbidity Survey Replication Am J Psychiatry, 2006.PMID 16741209
  14. [14]Copeland WE, Wolke D, Shanahan L, Costello EJ. Adult Functional Outcomes of Common Childhood Psychiatric Problems: A Prospective, Longitudinal Study JAMA Psychiatry, 2015.PMID 26176785
  15. [15]Wagner KD, Berard R, Stein MB, Wetherhold E, et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder Arch Gen Psychiatry, 2004.PMID 15520363
  16. [16]Strawn JR, Prakash A, Zhang Q, Pangallo BA, et al. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder J Am Acad Child Adolesc Psychiatry, 2015.PMID 25791145
  17. [17]Kearney CA, Albano AM. The functional profiles of school refusal behavior. Diagnostic aspects Behav Modif, 2004.PMID 14710711
  18. [18]Kearney CA. Forms and functions of school refusal behavior in youth: an empirical analysis of absenteeism severity J Child Psychol Psychiatry, 2007.PMID 17244270
  19. [19]King NJ, Tonge BJ, Heyne D, Pritchard M, et al. Cognitive-behavioral treatment of school-refusing children: a controlled evaluation J Am Acad Child Adolesc Psychiatry, 1998.PMID 9549960
  20. [20]Heyne D, King NJ, Tonge BJ, Rollings S, et al. Evaluation of child therapy and caregiver training in the treatment of school refusal J Am Acad Child Adolesc Psychiatry, 2002.PMID 12049443
  21. [21]Zhou X, Zhang Y, Furukawa TA, Cuijpers P, et al. Different Types and Acceptability of Psychotherapies for Acute Anxiety Disorders in Children and Adolescents: A Network Meta-analysis JAMA Psychiatry, 2019.PMID 30383099
  22. [22]Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, et al. Child/Adolescent anxiety multimodal study: evaluating safety J Am Acad Child Adolesc Psychiatry, 2015.PMID 25721183
  23. [23]Pine DS, Fox NA. Childhood antecedents and risk for adult mental disorders Annu Rev Psychol, 2015.PMID 25559116
  24. [24]Nicotra CM, Strawn JR. Advances in Pharmacotherapy for Pediatric Anxiety Disorders Child Adolesc Psychiatr Clin N Am, 2023.PMID 37201968
  25. [25]Keeton CP, Kolos AC, Walkup JT. Pediatric generalized anxiety disorder: epidemiology, diagnosis, and management Paediatr Drugs, 2009.PMID 19445546

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousEpilepsy in intellectual disabilityIntellectual disability psychiatryNextChild and adolescent depressionChild and adolescent psychiatry — depression